<?xml version="1.0" encoding="UTF-8"?>
<p>Biologics have now become treatment standards in many patients with the more severe forms of asthma or allergies. Again, no patients in the large Chinese series were reported to have being administered by biologics prior to COVID‐19. For treatment of severe allergic diseases with biologicals, a recent EAACI expert opinion article suggested continuation in otherwise healthy patients, while during COVID‐19 pandemic. Nevertheless, biologics should be paused until recovery in SARS‐CoV‐2–positive patients.
 <xref rid="pai13262-bib-0032" ref-type="ref">
  <sup>32</sup>
 </xref>
</p>
